Outcomes of rescue procedures in the management of locally recurrent ampullary tumors: A Pancreas 2000/EPC study

• Published in: Surgery 2023-05, Vol.173 (5), p.1254-1262
• Main Authors: Karam, Elias, Hollenbach, Marcus, Ali, Einas Abou, Auriemma, Francesco, Gulla, Aiste, Heise, Christian, Regner, Sara, Gaujoux, Sébastien, Regimbeau, Jean, Kähler, Georg, Seyfried, Steffen, Vaillant, Jean, de Ponthaud, Charles, Sauvanet, Alain, Birnbaum, David, Regenet, Nicolas, Truant, Stéphanie, Pérez-Cuadrado-Robles, Enrique, Bruzzi, Matthieu, Lupinacci, Renato, Brunel, Martin, Belfiori, Giulio, Barbier, Louise, Salamé, Ephrem, Souche, Francois, Schwarz, Lilian, Maggino, Laura, Salvia, Roberto, Gagniére, Johan, del Chiaro, Marco, Leung, Galen, Hackert, Thilo, Kleemann, Tobias, Paik, Woo, Caca, Karel, Dugic, Ana, Muehldorfer, Steffen, Schumacher, Brigitte, Albers, David
• Format: Article
• Language: English
• Subjects: Humanities and Social Sciences
• ISSN: 0039-6060; 1532-7361
• DOI: 10.1016/j.surg.2022.12.011

BackgroundAmpullary lesions are rare and can be locally treated either with endoscopic papillectomy or transduodenal surgical ampullectomy. Management of local recurrence after a first-line treatment has been poorly studied.MethodsPatients with a local recurrence of an ampullary lesion initially treated with endoscopic papillectomy or transduodenal surgical ampullectomy were retrospectively included from a multi-institutional database (58 centers) between 2005 and 2018.ResultsA total of 103 patients were included, 21 (20.4%) treated with redo endoscopic papillectomy, 14 (13.6%) with transduodenal surgical ampullectomy, and 68 (66%) with pancreaticoduodenectomy. Redo endoscopic papillectomy had low morbidity with 4.8% (n = 1) severe to fatal complications and a R0 rate of 81% (n = 17). Transduodenal surgical ampullectomy and pancreaticoduodenectomy after a first procedure had a higher morbidity with Clavien III and more complications, respectively, 28.6% (n = 4) and 25% (n = 17); R0 resection rates were 85.7% (n = 12) and 92.6% (n = 63), both without statistically significant difference compared to endoscopic papillectomy (P = .1 and 0.2). Pancreaticoduodenectomy had 4.4% (n = 2) mortality. No deaths were registered after transduodenal surgical ampullectomy or endoscopic papillectomy. Recurrences treated with pancreaticoduodenectomy were more likely to be adenocarcinomas (79.4%, n = 54 vs 21.4%, n = 3 for transduodenal surgical ampullectomy and 4.8%, n = 1 for endoscopic papillectomy, P < .0001). Three-year overall survival and disease-free survival were comparable.ConclusionEndoscopy is appropriate for noninvasive recurrences, with resection rate and survival outcomes comparable to surgery. Surgery applies more to invasive recurrences, with transduodenal surgical ampullectomy rather for carcinoma in situ and early cancers and pancreaticoduodenectomy for more advanced tumors.